Decision: Favourable
Study Title:
A double blind, randomized, placebo-controlled trial evaluating the efficacy and safety of BI 1015550 over at least 52 weeks in patients with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)
NREC Code:
22-NREC-CT-159
Decision:
Favourable
Meeting Date:
19/10/2022
Study Type:
CT application
Principal Investigator:
Michael P. Keane
PI Institution:
St Vincent's University Hospital
Sponsor:
Boehringer Ingelheim International GmbH